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Open access under CC BY-NC-ND license.Policy issues around biobased chemicals are similar to
those for biobased plastics. However, there are significant
differences that arise from differences in production
volumes and the more specific applications of most che-
micals. The drivers for biobased chemicals production are
similar to those for biobased plastics, particularly the
environmental drivers. However, in Europe, biobased
chemical production is further driven by the need to
improve the competitiveness of the chemicals industry.
Drivers for biobased chemicals
In 1994, the first sentence in an article by Frost and
Lievense [1] read: ‘Although aromatics are currently syn-
thesized from benzene, toluene, and xylene derived from
fossil feedstocks, environmental considerations and the
scarcity of petroleum will necessitate development of other
industrial routes to these molecules in nations such as the
United States.’
Essentially, the drivers for the production of biobased
chemicals are still the same, now that we have a deeper
knowledge of the consequences of climate change and the
need for energy security as new crude oil discoveries are
not growing apace with demand. Enlightened in its day,
the article went on to describe the derivation of aromatics
by biocatalytic routes that use water instead of aromatic
solvents, and that use low reaction temperatures and
pressures. Nowadays biobased routes to organic chemicals
have gone well beyond aromatics.
In Europe, an additional driver has derived from the
desire of the chemical industry to remain competitive. Data
for the ten years from 1999 to 2009 indicate that the EU
has been the clear leader in terms of world chemical sales,
but the region has gradually lost ground to Asia [2].
What are the biobased chemicals?
The numbers and types of chemicals that can be produced
through a biomass origin and/or a bioprocessing route is
surprisingly large. The list includes: many platform che-
micals, such as propane- and butanediols, carboxylic acids,
short chain olefins, isoprene, and ethanol; amino acids;
vitamins; polymers such as alginate and xanthan gum; and
the increasingly commercially important industrial
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BC, Canada.powders. In 2004 the US Department of Energy (DoE)
[3] identified 12 chemicals or chemical classes as potential
building blocks or platform chemicals from which many
value-added chemicals may be derived. This great diversi-
ty means it is impossible to create the same policy frame-
work for, say, very low production volume chemicals such
as enzymes, and a biobased version of ethylene, the largest
production volume organic chemical in existence [4].
Growth of the biobased chemicals industry
Figure 1a shows how the biobased chemicals industry
has grown throughout the 2000s (from [5]), and Figure 1b
gives a prediction from the US Department of Agricul-
ture (USDA) for growth to 2025 [6]. It is evident from
both of these sources that in recent years the biobased
chemicals subsector has grown much faster than the
petrochemicals sector, and is predicted to continue to
do this. The USDA study projects that the global chemi-
cal industry will grow 3–6% per annum through to 2025,
with the biobased chemicals share of that market rising
from 2% (2008) to 22% by 2025. Such a situation is one
that attracts the interest of policy makers for various
reasons, for example, the need for proper regulation and
removal of barriers to growth if growth is considered
beneficial to society and industry.
Cost and performance
It is impossible to market biobased chemicals on their
green credentials alone. In a world driven by the triple-
bottom-line, the economics and societal issues must also
favour bio- in comparison with petrochemicals. However,
that means that this very young industry must compete
head-on with the petrochemicals industry, which has had
many decades to perfect its processes. Therefore, if there is
a long-term triple-bottom-line advantage to come from
biobased chemicals, society should expect to have to incen-
tivise the industry till such times as it does compete on
price and performance.
Societal concerns
Regulation
The pace of development of biobased chemicals has out-
stripped rigorous review of the governance and regulatory
implications. The perception that anything biobased is
inherently more benign and sustainable is inherently
flawed – they are, after all, still chemicals. In the US,
for example, the critical regulation is the Toxic Substances219
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2005 2010 2025
Sector Total Biobased Total Biobased Total Biobased
Commodity 475 0.9 550 5-11 857 50-86
Specialty 375 5 435 87-110 679 300-340
Fine 100 15 125 25-32 195 88-98
Polymer 250 0.3 290 15-30 452 45-90
Total 1,200 21.2 1,400 132-183 2,183 483-614
2001
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Figure 1. Trends in production of biobased chemicals in relation to petrochemicals. (a) The global growth of the biobased chemicals and polymers between 2001 and 2010
(Adapted from [5]). (b) US predictions for growth of the biobased industry to 2025 (from [6]).
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is, the US Environmental Protection Agency (EPA) is
required to balance the regulatory costs versus the likely
benefits of a chemical regulation. An inventory of chemi-
cals was created for TSCA in the 1970s, and naturally most
of these were fossil derived. As such, many of the biobased
chemicals entering the market are and will be considered
new chemicals subject to TSCA regulation. Many of the
TSCA Inventory chemicals are at least partially exempt
from review, but new biobased chemicals may not be. Thus,
it is not only in the interests of society that proper regula-
tion is carried out; it has major implications for the man-
ufacturers. A clearly written exposition of the US situation
is given by Bergeson et al. [7]. The situation in Europe
seems somewhat different. REACH is the European Com-
munity Regulation on chemicals and their safe use (EC
1907/2006, http://eur-lex.europa.eu/LexUriServ/LexUri-
Serv.do?uri=oj:l:2006:396:0001:0849:en:pdf). It deals with
the registration, evaluation, authorisation, and restriction
of chemical substances. REACH aims to improve the pro-
tection of human health and the environment, while at the
same time enhancing innovation and competitiveness of
the EU chemicals industry. To the best of our knowledge,
biobased chemicals are treated identically to petrobased
chemicals within REACH.
Sustainability
A major goal of sustainability is reduction in green house
gas (GHG) emissions. With biobased chemicals, a compo-
nent of the sustainability picture is the mild bioprocess
conditions used, for example, low temperature and pres-
sure. The biggest issue is then the availability of sustain-
ably produced biomass, and the related issues of land
availability and use. A bioeconomy makes use of biotech-
nology in the production of chemicals and pharmaceuticals.
Although this is economically an important issue, it has a
minor impact on the amounts of raw materials used for the
manufacture of these products compared to those required
for bioenergy [8] for two main reasons: production volumes
of plastics and chemicals are much lower than those of
fuels; and, particularly in the case of bioplastics, they
exhibit higher land area efficiency compared to biofuels220[9]. Therefore biobased chemicals create much less of a
concern for land use than concerns associated with bioe-
nergy. For example, the study to determine if US agricul-
ture and forestry could sustainably produce one billion tons
of dry biomass annually is concerned with the displace-
ment of 30% of the nation’s petroleum consumption [10].
Jobs and other bioeconomy issues
A feature of the development of industrial biotechnology in
Europe is a competition between the bioenergy and bio-
materials sectors. Although there is considerable policy
support for the bioenergy industry, there is almost no
support for industrial materials use. This situation incen-
tivises use of biomass for energy more than for biobased
chemicals and plastics. Carus et al. [11] have stated that
materials use can directly support 5–10 times more em-
ployment and 4–9 times the value-added compared with
energy uses, principally due to longer, more complex sup-
ply chains for material use. They have even argued that the
market distortion could risk driving the existing wood
pulp, paper, and board industry out of Europe if there is
sufficient policy incentive to switch to an energy wood
pellet industry, with the lowest added value and employ-
ment.
Biobased succinic acid: the argument for biobased in a
nutshell
Succinic acid is one of the top 12 chemicals identified by the
US DoE [3] as a potential biobased building block, with
good reason. The market for only four of the major succinic
acid derivatives is estimated to be $4.8 billion per year [12].
It is produced efficiently via petrochemical routes, but this
involves the oxidation of butane or benzene, and this is
redolent of the warnings of Frost and Lievense [1]. It can be
produced by biological routes: what is more, although
ethanol fermentation, for example, produces CO2, succi-
nate fermentation fixes CO2, thereby consuming it. The
biobased production is therefore potentially much more
eco-friendly compared to the petrochemical process. The
natural fermentative production is, however, inefficient
and work is underway to improve yields using techniques
of metabolic engineering (e.g., [13]).
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Figure 2. Biobased indigo. (a) A naturally occurring bacterium that produces indigo (from the corresponding author’s collection). (b) Eco-efficiency analysis of a
biotechnology-derived and a plant-derived indigo in comparison with petroderived types of indigo (Adapted from [14]). This analysis indicates that two petroderived types
are more eco-efficient than two biobased types [14].
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The chemical synthesis of blue jeans dye (indigo) classical-
ly derives from either aniline or anthranilic acid; both of
which are derived from nonrenewable fossil fuels. Factory
emissions from the chemical synthesis of indigo, for exam-
ple, ammonia, aniline, and cyanide compounds, are serious
environmental and health concerns. However, there are
naturally occurring bacteria that produce indigo
(Figure 2a). Yields from naturally occurring bacteria are
low and they are not suited to the conditions of industrial
fermentation. Much effort has gone into the production of
genetically engineered production strains. However, an eco-
efficiency analysis [14] has demonstrated that biobased indi-
go processes are less efficient than chemical and electrochem-
ical processes. This is illustrated in Figure 2b (from [14]).
This is not to say that there is no future for biobased
indigo – recently a continuous culture system for its indus-
trial production was described, with high product yield and
long-term plasmid stability [15]. Generally, there is grow-
ing dissatisfaction with environmental footprint method-
ologies, and with life cycle analysis (LCA) specifically (e.g.,
[16]); a situation requiring the urgent attention of policy
makers.
Concluding remarks
By literature scrutiny and two examples, we have
attempted to illustrate that the introduction of biobased
chemicals, specifically driven by climate change, energy
security, and chemical industry competitiveness, is a mat-
ter for both hope and concern. The rapid development of
this innovative industry has outpaced policy development
in several aspects that have societal concerns. Smarter and
more timely regulation would improve the assessment of
the qualities of newly developed products – renewable,
biobased does not necessarily mean better for the environ-
ment. Meanwhile, the market distortion created by the
substantial policy support for bioenergy could potentially
inhibit the innovation and market uptake of new chemicalsas more biomass is diverted towards bioenergy. This has
potential negative impacts on bioeconomy jobs.
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Agroscope Reckenholz-Ta¨nikon Research Station ART, Reckenholzstr. 191, 8046 Zurich, SwitzerlandThe government of Switzerland has responded to van-
dalism of field experiments with genetically modified
(GM) crops by establishing a protected field site. This
site will enable research groups to conduct experiments
without having to install and pay for security measures.
This could be a model for other European countries who
wish to evaluate the advantages and disadvantages of
GM crops in an objective and scientific manner and
without the interference of vandalism.
The use of crops derived through recombinant DNA tech-
nology has increased in importance in many parts of the
world. In 2011, as much as 10% of the arable crop area in
the world was planted with GM crops [1]. The number of
commercialized transgenic events worldwide is predicted
to increase by a factor of four from around 30 in 2008 to over
120 in 2015 [2]. In Europe, however, adoption of genetically
improved plants is very low, with only two GM crops being
approved for commercial use. This includes Bt maize,
which produces a bacterium-derived Cry protein from
Bacillus thuringiensis that protects against key lepidop-
teran pests, and a starch-modified potato.
Europe has traditionally been very strong in plant
sciences and the EU has been providing strong financial
support for research on GM crops [3,4]. However, the debate
on GM crops is mainly driven by concerns about adverse
impacts on the environment, human and animal health, and
socioeconomics [5]. One main obstacle to the development
and the study of GM plants is the difficulty in conducting
field experiments. The EU legislation that governs field
trials and commercial release of GM crops [6] recognizes
the need for field research but also requires that the public be
notified of the precise locations of trials. The latter makes it
easy for activist groups to locate and vandalize such field
experiments. As a consequence, the number of field trials
attacked and (partly) destroyed is high [7,8]. Until 2010 more
than 100 experiments in Europe had been destroyed. Thus,
public institutions in particular are increasingly rejecting
the idea of conducting field research with GM crops or are
conducting the experiments in countries such as the USA,where gaining government approval for field trials is easier
and where the incidence of vandalism is much lower. Con-
sequently, the number of field trials conducted in Europe has
been steadily declining. As an indicator of this, the summary
notifications of field experiments with GM crops in the EU
have declined from around 250 per year in the late 1990s to
fewer than 50 in 2011 [7]. It thus appears that vandalism of
field experiments with GM crops in Europe is a major factor
restricting the ability of researchers to evaluate rationally
the benefits and risks of this agricultural and environmental
technology. This is an unacceptable situation, and as Atkin-
son and Urwin [9] have stated: ‘If EU governments cannot
protect the trials they authorize, they should establish
secure, vandal-proof national testing centres’.
As of January 2013 in Switzerland, only six applications
for field experiments with GM plants had been submitted;
four applications were approved and two were rejected
(Table 1). Before the adoption of the Swiss gene technology
law in 2003, only two field experiments with GM plants
(transgenic potatoes expressing the coat protein of potato
virus Y) had been conducted, and these were in 1991 and
1992 [10]. Today, no GM crop is approved for commercial
release, and in 2005 voters approved a 5-year moratorium on
the commercial use of GM plants. In 2010 and 2012, this
moratorium was extended by the Federal Council and is now
in place until 2017. Scientific research including field experi-
ments with GM plants is exempt from the moratorium.
From 2007 to 2012, the National Research Programme
NRP 59 was launched by the Swiss National Science Foun-
dation to ‘examine the benefits and risks of genetically
modified (GM) plants under the ecological, social, economic,
legal and political conditions of Switzerland’ (http://
www.nrp59.ch). One main area of interest of the program
was on ‘plant biotechnology and the environment’. Within
this priority area, nine projects were part of a consortium
studying transgenic wheat with respect to mildew resis-
tance, interaction with the environment, and impact on non-
target organisms and ecological processes. This research
included open field trials at two locations, the Agroscope
research stations at Reckenholz (Zurich) and Pully (near
Lausanne). The importance of field experiments for investi-
gating research questions that cannot be answered in closed
systems is well documented [11–14]. Trials were conducted
